<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Bajrami B</submitter><funding>FAMRI</funding><funding>Natural Science Foundation of Tianjin City</funding><funding>NIAID NIH HHS</funding><funding>NHLBI NIH HHS</funding><funding>National Institutes of Health</funding><funding>National Natural Sciences Foundation of China</funding><pagination>1999-2018</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5030805</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>213(10)</volume><pubmed_abstract>Cytokine-induced neutrophil mobilization from the bone marrow to circulation is a critical event in acute inflammation, but how it is accurately controlled remains poorly understood. In this study, we report that CXCR2 ligands are responsible for rapid neutrophil mobilization during early-stage acute inflammation. Nevertheless, although serum CXCR2 ligand concentrations increased during inflammation, neutrophil mobilization slowed after an initial acute fast phase, suggesting a suppression of neutrophil response to CXCR2 ligands after the acute phase. We demonstrate that granulocyte colony-stimulating factor (G-CSF), usually considered a prototypical neutrophil-mobilizing cytokine, was expressed later in the acute inflammatory response and unexpectedly impeded CXCR2-induced neutrophil mobi</pubmed_abstract><journal>The Journal of experimental medicine</journal><pubmed_title>G-CSF maintains controlled neutrophil mobilization during acute inflammation by negatively regulating CXCR2 signaling.</pubmed_title><pmcid>PMC5030805</pmcid><funding_grant_id>R01 HL092020</funding_grant_id><funding_grant_id>31471116</funding_grant_id><funding_grant_id>R01 AI103142</funding_grant_id><funding_grant_id>12JCZDJC24600</funding_grant_id><funding_grant_id>P01 HL095489</funding_grant_id><funding_grant_id>R01AI103142</funding_grant_id><funding_grant_id>CIA 123008</funding_grant_id><funding_grant_id>R01HL092020</funding_grant_id><funding_grant_id>31271484</funding_grant_id><pubmed_authors>Kwak HJ</pubmed_authors><pubmed_authors>Nombela-Arrieta C</pubmed_authors><pubmed_authors>Mondal S</pubmed_authors><pubmed_authors>Bajrami B</pubmed_authors><pubmed_authors>Zhu H</pubmed_authors><pubmed_authors>Zhang YC</pubmed_authors><pubmed_authors>Park SY</pubmed_authors><pubmed_authors>Silberstein LE</pubmed_authors><pubmed_authors>Loison F</pubmed_authors><pubmed_authors>Luo HR</pubmed_authors><pubmed_authors>Sakai J</pubmed_authors><pubmed_authors>Geng G</pubmed_authors><pubmed_authors>Hou Q</pubmed_authors><pubmed_authors>Karatepe K</pubmed_authors><pubmed_authors>Xu Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>G-CSF maintains controlled neutrophil mobilization during acute inflammation by negatively regulating CXCR2 signaling.</name><description>Cytokine-induced neutrophil mobilization from the bone marrow to circulation is a critical event in acute inflammation, but how it is accurately controlled remains poorly understood. In this study, we report that CXCR2 ligands are responsible for rapid neutrophil mobilization during early-stage acute inflammation. Nevertheless, although serum CXCR2 ligand concentrations increased during inflammation, neutrophil mobilization slowed after an initial acute fast phase, suggesting a suppression of neutrophil response to CXCR2 ligands after the acute phase. We demonstrate that granulocyte colony-stimulating factor (G-CSF), usually considered a prototypical neutrophil-mobilizing cytokine, was expressed later in the acute inflammatory response and unexpectedly impeded CXCR2-induced neutrophil mobi</description><dates><release>2016-01-01T00:00:00Z</release><publication>2016 Sep</publication><modification>2025-04-22T06:33:49.51Z</modification><creation>2019-10-18T07:00:57Z</creation></dates><accession>S-EPMC5030805</accession><cross_references><pubmed>27551153</pubmed><doi>10.1084/jem.20160393</doi></cross_references></HashMap>